Home Biosimilar Antibodies Others Antibody-Drug Conjugate inhibitor Labetuzumab govitecan For research use only.
Not for use in humans.

Labetuzumab govitecan

Synonyms: IMMU-130

Labetuzumab govitecan (IMMU-135) is a humanised anti-CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5) antibody linked site-specifically to the active metabolite of irinotecan SN-38 via a proprietary linker. Labetuzumab govitecan can be used for research on colorectal cancer.

Labetuzumab govitecan

CAS No. 1469876-18-3

Click to purchase the isotype control of Labetuzumab govitecan

Purity & Quality Control

Batch: D404801 Purity: 99% Protein concentration: 4.91 mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Antibody-Drug Conjugate Inhibitors

Biological Activity

Description Labetuzumab govitecan (IMMU-135) is a humanised anti-CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5) antibody linked site-specifically to the active metabolite of irinotecan SN-38 via a proprietary linker. Labetuzumab govitecan can be used for research on colorectal cancer.

Product Details

CAS No. 1469876-18-3
ADC antiody Labetuzumab
ADC linker Lysine; a maleimide-type cleavable linker
ADC cytotoxin SN-38
Formulation 1xPBS
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Labetuzumab govitecan | Labetuzumab govitecan supplier | purchase Labetuzumab govitecan | Labetuzumab govitecan cost | Labetuzumab govitecan manufacturer | order Labetuzumab govitecan | Labetuzumab govitecan distributor